Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Tackles 3-D Printing Considerations In Draft Guidance

This article was originally published in The Gray Sheet

Executive Summary

A draft guidance issued by FDA on additive manufacturing, or 3-D printing, of medical devices is meant to be a starting point for an industry that is growing exponentially. The document outlines recommendations on topics such as device design, software considerations and material testing requirements.


Related Content

3D-Printing Final Guidance Clarifies Manufacturing Practice Expectations
US FDA Works To Finalize 3D Printing Guidance; Industry Asks For More
New FDA Web Page Aims To Clarify Position On 3D Printing
3D Printing: Will Personalized Medical Devices Be The Next Big Thing?
FDA Will Talk 3-D Printing At October Workshop
3-D Printed Implants Hit The Market, Pave The Way For More Personalized Devices
‘The Sky’s The Limit’ For 3-D Printed Medical Devices, FDA Says





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts